LAUREN BROLUND: Open Payments
NPI 1669825873 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,413 in 137 payments from 23 companies in 2025. Trend: 2023 $2,442 · 2024 $3,959 · 2025 $3,413
Food & beverage: $2,663Consulting: $750
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 1 | $750 |
| UCB, Inc. | 9 | $372 |
| GENZYME CORPORATION | 11 | $312 |
| ABBVIE INC. | 30 | $309 |
| Organon LLC | 9 | $266 |
| Arcutis Biotherapeutics, Inc. | 14 | $188 |
| Galderma Laboratories, L.P. | 11 | $171 |
| Janssen Biotech, Inc. | 13 | $147 |
| Regeneron Healthcare Solutions, Inc. | 7 | $144 |
| LEO Pharma Inc. | 5 | $140 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, Zoryve, VTAMA, NEMLUVIO, TREMFYA, ADBRY.
Industry payments across FL — which companies pay providers there.
